Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
Benitec Biopharma (BNTC) Stock Price & Analysis
193 Followers
BNTC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.86 - $9.01
Previous Close$4.8
Volume3.52M
Average Volume (3M)18.87K
Market Cap
$12.44M
Enterprise Value$6.47M
Total Cash (Recent Filing)$6.60M
Total Debt (Recent Filing)$623.00K
Price to Earnings (P/E)-0.4
Beta1.56
Next Earnings
May 13, 2024EPS Estimate
-$0.78Last Dividend Ex-Date
Jun 01, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)-10.90
Shares Outstanding2,592,434
10 Day Avg. Volume21,616
30 Day Avg. Volume18,873
Standard Deviation0.25
R-Squared0.05
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.80
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue95.10
Enterprise Value/Gross Profit101.04
Enterprise Value/Ebitda-0.42
Forecast
1Y Price Target
$10.00Price Target Upside46.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Benitec Biopharma News
PremiumCompany Announcements
Benitec Biopharma’s $40 Million Equity Financing Deal
PremiumCompany Announcements
Benitec Biopharma Showcases Encouraging Clinical Trial Results
PremiumCompany Announcements
Benitec Biopharma Awards Stock Options to Top Executives
Ownership Overview
41.58% Insiders
15.10% Mutual Funds
15.82% Other Institutional Investors
27.49% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
BNTC FAQ
What was Benitec Biopharma Ltd’s price range in the past 12 months?
Benitec Biopharma Ltd lowest stock price was $1.86 and its highest was $9.01 in the past 12 months.
What is Benitec Biopharma Ltd’s market cap?
Currently, no data Available
When is Benitec Biopharma Ltd’s upcoming earnings report date?
Benitec Biopharma Ltd’s upcoming earnings report date is May 13, 2024 which is in 23 days.
How were Benitec Biopharma Ltd’s earnings last quarter?
Benitec Biopharma Ltd released its earnings results on Feb 13, 2024. The company reported -$2.64 earnings per share for the quarter, missing the consensus estimate of -$0.39 by -$2.25.
Is Benitec Biopharma Ltd overvalued?
According to Wall Street analysts Benitec Biopharma Ltd’s price is currently Undervalued.
Does Benitec Biopharma Ltd pay dividends?
Benitec Biopharma Ltd pays a Notavailable dividend of $0.51 which represents an annual dividend yield of N/A. See more information on Benitec Biopharma Ltd dividends here
What is Benitec Biopharma Ltd’s EPS estimate?
Benitec Biopharma Ltd’s EPS estimate is -$0.78.
How many shares outstanding does Benitec Biopharma Ltd have?
Benitec Biopharma Ltd has 2,592,434 shares outstanding.
What happened to Benitec Biopharma Ltd’s price movement after its last earnings report?
Benitec Biopharma Ltd reported an EPS of -$2.64 in its last earnings report, missing expectations of -$0.39. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Benitec Biopharma Ltd?
Currently, no hedge funds are holding shares in BNTC
---
Benitec Biopharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (46.63% Upside)
$10.00 (46.63% Upside)
Blogger Sentiment
Bullish
BNTC Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 4.6%
Last 30 Days ▼ 4.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.31%
12-Months-Change
Fundamentals
Return on Equity
-178.30%
Trailing 12-Months
Asset Growth
79.36%
Trailing 12-Months
Company Description
Benitec Biopharma Ltd
Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in North Sydney, Australia.
---
BNTC Stock 12 Months Forecast
Average Price Target
$10.00
▲(46.63% Upside)
Technical Analysis
Best Analysts Covering BNTC
1 Year
1 Year Success Rate
6/10 ratings generated profit
1 Year Average Return
+19.61%
reiterated a buy rating 2 months ago
Copying Silvan Tuerkcan's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +19.61% per trade.
---